IN2012DN02793A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02793A IN2012DN02793A IN2793DEN2012A IN2012DN02793A IN 2012DN02793 A IN2012DN02793 A IN 2012DN02793A IN 2793DEN2012 A IN2793DEN2012 A IN 2793DEN2012A IN 2012DN02793 A IN2012DN02793 A IN 2012DN02793A
- Authority
- IN
- India
- Prior art keywords
- pyrrolidine
- pharmaceuticals
- oxo
- preparing
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09173912 | 2009-10-23 | ||
| PCT/EP2010/006434 WO2011047860A1 (en) | 2009-10-23 | 2010-10-21 | 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02793A true IN2012DN02793A (de) | 2015-07-24 |
Family
ID=42034570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2793DEN2012 IN2012DN02793A (de) | 2009-10-23 | 2010-10-21 |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US8822508B2 (de) |
| EP (1) | EP2491045B1 (de) |
| JP (1) | JP5808020B2 (de) |
| KR (1) | KR20120102058A (de) |
| CN (1) | CN102574869A (de) |
| AR (1) | AR078722A1 (de) |
| AU (1) | AU2010310100B2 (de) |
| BR (1) | BR112012009310B8 (de) |
| CA (1) | CA2778194C (de) |
| CL (1) | CL2012001031A1 (de) |
| CY (1) | CY1117288T1 (de) |
| DK (1) | DK2491045T3 (de) |
| EA (1) | EA201200616A1 (de) |
| ES (1) | ES2565515T3 (de) |
| HR (1) | HRP20160263T1 (de) |
| HU (1) | HUE028668T2 (de) |
| IL (1) | IL218696A0 (de) |
| IN (1) | IN2012DN02793A (de) |
| MA (1) | MA33679B1 (de) |
| ME (1) | ME02355B (de) |
| MX (1) | MX347070B (de) |
| PE (1) | PE20121562A1 (de) |
| PL (1) | PL2491045T3 (de) |
| RS (1) | RS54595B1 (de) |
| SI (1) | SI2491045T1 (de) |
| SM (1) | SMT201600076B (de) |
| TN (1) | TN2012000147A1 (de) |
| TW (1) | TW201118103A (de) |
| WO (1) | WO2011047860A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5969003B2 (ja) * | 2011-04-18 | 2016-08-10 | ユセベ ファルマ ソシエテ アノニム | ２−オキソ−１−イミダゾリジニルイミダゾチアジアゾール誘導体 |
| US9581654B2 (en) | 2013-02-12 | 2017-02-28 | Johnson Controls Technology Company | Vehicle battery monitoring system |
| ES2860298T3 (es) | 2014-01-21 | 2021-10-04 | Janssen Pharmaceutica Nv | Combinaciones que comprenden moduladores alostéricos positivos del receptor glutamatérgico metabotrópico de subtipo 2 y su uso |
| BR112016016390B1 (pt) | 2014-01-21 | 2023-04-11 | Janssen Pharmaceutica Nv | Produto compreendendo modulador alostérico positivo do receptor glutamatérgico metabotrópico do subtipo 2 e ligante da proteína de vesícula sináptica 2a |
| JP7130729B2 (ja) * | 2017-07-10 | 2022-09-05 | ユーシービー バイオファルマ エスアールエル | ２－オキソ－１－イミダゾリジニルイミダゾチアジアゾール誘導体 |
| EP3652183B1 (de) * | 2017-07-10 | 2021-09-08 | UCB Biopharma SRL | 2-oxo-1,3-oxazolidinyl imidazothiadiazole derivative |
| CN107827870B (zh) * | 2017-10-24 | 2019-11-08 | 江苏仁明生物科技有限公司 | 一种正电子药物[18f]fpmmp及其制备方法与中间体 |
| MA51126A (fr) * | 2017-12-12 | 2020-10-21 | UCB Biopharma SRL | Dérivés de 2-oxo-1-pyrrolidinyl imidazothiadiazole |
| MX2020011170A (es) * | 2018-05-08 | 2020-11-12 | UCB Biopharma SRL | Derivados de 1-imidazotiadiazol-2h-pirrol-5-ona. |
| CN113549052B (zh) * | 2021-07-09 | 2022-09-02 | 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) | 4-苯基-1-（吡啶-4-基甲基）吡咯烷-2-酮衍生物及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8412357D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| GB8412358D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| CN1906160A (zh) * | 2003-12-02 | 2007-01-31 | Ucb股份有限公司 | 咪唑衍生物及其制备方法和其应用 |
| ES2441178T3 (es) * | 2005-06-01 | 2014-02-03 | Ucb Pharma, S.A. | Derivados de 2-oxo-1-pirrolidina, procedimientos para prepararlos y el uso terapéutico de los mismos sobre el sistema nervioso central |
-
2010
- 2010-10-21 US US13/502,546 patent/US8822508B2/en active Active
- 2010-10-21 JP JP2012534579A patent/JP5808020B2/ja active Active
- 2010-10-21 PE PE2012000526A patent/PE20121562A1/es not_active Application Discontinuation
- 2010-10-21 DK DK10781818.9T patent/DK2491045T3/en active
- 2010-10-21 SI SI201031137T patent/SI2491045T1/sl unknown
- 2010-10-21 ME MEP-2016-44A patent/ME02355B/de unknown
- 2010-10-21 WO PCT/EP2010/006434 patent/WO2011047860A1/en active Application Filing
- 2010-10-21 CN CN2010800476319A patent/CN102574869A/zh active Pending
- 2010-10-21 EP EP10781818.9A patent/EP2491045B1/de active Active
- 2010-10-21 PL PL10781818T patent/PL2491045T3/pl unknown
- 2010-10-21 CA CA2778194A patent/CA2778194C/en active Active
- 2010-10-21 EA EA201200616A patent/EA201200616A1/ru unknown
- 2010-10-21 MX MX2012003839A patent/MX347070B/es active IP Right Grant
- 2010-10-21 ES ES10781818.9T patent/ES2565515T3/es active Active
- 2010-10-21 AU AU2010310100A patent/AU2010310100B2/en active Active
- 2010-10-21 KR KR1020127013216A patent/KR20120102058A/ko not_active Application Discontinuation
- 2010-10-21 TW TW099135866A patent/TW201118103A/zh unknown
- 2010-10-21 IN IN2793DEN2012 patent/IN2012DN02793A/en unknown
- 2010-10-21 RS RS20160156A patent/RS54595B1/en unknown
- 2010-10-21 HU HUE10781818A patent/HUE028668T2/en unknown
- 2010-10-21 BR BR112012009310A patent/BR112012009310B8/pt active IP Right Grant
- 2010-10-22 AR ARP100103864A patent/AR078722A1/es unknown
-
2012
- 2012-03-18 IL IL218696A patent/IL218696A0/en unknown
- 2012-03-29 TN TNP2012000147A patent/TN2012000147A1/en unknown
- 2012-04-19 MA MA34783A patent/MA33679B1/fr unknown
- 2012-04-23 CL CL2012001031A patent/CL2012001031A1/es unknown
-
2016
- 2016-03-14 HR HRP20160263TT patent/HRP20160263T1/hr unknown
- 2016-03-15 CY CY20161100217T patent/CY1117288T1/el unknown
- 2016-03-16 SM SM201600076T patent/SMT201600076B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02793A (de) | ||
| MX2011008864A (es) | Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales. | |
| MX2010007587A (es) | Compuestos que comprenden un grupo ciclobutoxi. | |
| WO2009135646A3 (en) | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale | |
| MX2011005934A (es) | Compuestos organicos. | |
| MY162411A (en) | Crystalline forms of a macrolide, and uses therefor | |
| EP2251038A4 (de) | Feste dispersion, pharmazeutische zusammensetzungen damit und verfahren zu ihrer herstellung | |
| AU2010233994A8 (en) | Bispecific anti-ErbB-3/anti-c-Met antibodies | |
| IN2012DN05125A (de) | ||
| GB201106743D0 (en) | Novel compounds | |
| IL225626A0 (en) | The history of pyrrolidinone, their preparation and remote preparations containing them | |
| CA2830549C (en) | Methods and compositions for preparing noribogaine from voacangine | |
| MX2011014019A (es) | Derivados de diazahomoadamantano y sus metodos de uso. | |
| WO2009115084A3 (de) | Pyrrolopyrimidin-derivate und deren verwendungen | |
| WO2010049449A3 (en) | Novel salts of sunitinib | |
| MX2012013855A (es) | Compuestos de oligobenzamida y su uso. | |
| MX2016000900A (es) | Nuevos derivados de indol y de pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| IL207183A (en) | Dihydroindolone compounds, a process for their preparation and their pharmaceutical compositions | |
| UA118562C2 (uk) | Модулятори рецептора cxcr7 | |
| WO2011050054A3 (en) | Coumarin compounds as receptor modulators with therapeutic utility | |
| MX2014004210A (es) | Derivados de 2-oxo-piperidinilo. | |
| MX2013013436A (es) | Derivados de indol sustituidos para el tratamiento de transtornos inmunologicos. | |
| MX349563B (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
| GB0615105D0 (en) | Novel compounds | |
| MX2011008126A (es) | Compuestos de indol sustituidos como moduladores del receptor 1 de bradiquinina. |